Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
902.15
10.60 (1.19%) Cadila Healthcare informs about conference call
Date: 29-01-2022Cadila Healthcare has informed that it enclosed Q3 FY22 post results conference call details.
The above information is a part of company’s filings submitted to BSE.